These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31217618)

  • 1. Expression of CD133 as a cancer stem cell marker in invasive gastric carcinoma.
    Attia S; Atwan N; Arafa M; Shahin RA
    Pathologica; 2019 Mar; 111(1):18-23. PubMed ID: 31217618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging roles of CD133 in the treatment of gastric cancer, a novel stem cell biomarker and beyond.
    Soleimani A; Dadjoo P; Avan A; Soleimanpour S; Rajabian M; Ferns G; Ryzhikov M; Khazaei M; Hassanian SM
    Life Sci; 2022 Mar; 293():120050. PubMed ID: 35026215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD133 expression is correlated with chemoresistance and early recurrence of gastric cancer.
    Lee HH; Seo KJ; An CH; Kim JS; Jeon HM
    J Surg Oncol; 2012 Dec; 106(8):999-1004. PubMed ID: 22674531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancerous and non-neoplastic stem cells in the stomach similarly express CD44 and CD133.
    Feitosa NPP; Pereira VBM; Silva BGB; Queroz AVF; Rodrigues BJ; Costa MLV; Alencar CH; Lima-Júnior RCP; Wong DVT; Frota CC; Almeida PRC
    Acta Histochem; 2021 Oct; 123(7):151787. PubMed ID: 34517259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD133+/CD166+ human gastric adenocarcinoma cells present the properties of neoplastic stem cells and emerge more malignant features.
    Ni T; Wang H; Zhan D; Tao L; Lv M; Wang W; Chu Z; Zhou Z; Sunagawa M; Liu Y
    Life Sci; 2021 Mar; 269():119021. PubMed ID: 33450261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of CD133 expression in gastric carcinoma.
    Ishigami S; Ueno S; Arigami T; Uchikado Y; Setoyama T; Arima H; Kita Y; Kurahara H; Okumura H; Matsumoto M; Kijima Y; Natsugoe S
    Anticancer Res; 2010 Jun; 30(6):2453-7. PubMed ID: 20651407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant Expression of Markers of Cancer Stem Cells in Gastric Adenocarcinoma and their Relationship to Vasculogenic Mimicry.
    Zhou L; Yu L; Feng ZZ; Gong XM; Cheng ZN; Yao N; Wang DN; Wu SW
    Asian Pac J Cancer Prev; 2015; 16(10):4177-83. PubMed ID: 26028069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of putative markers of cancer stem cells in gastric cancer: A retrospective cohort study.
    Chen XL; Chen XZ; Wang YG; He D; Lu ZH; Liu K; Zhang WH; Wang W; Li CC; Xue L; Zhao LY; Yang K; Liu JP; Zhou ZG; Hu JK; Mo XM
    Oncotarget; 2016 Sep; 7(38):62049-62069. PubMed ID: 27557490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer.
    Wakamatsu Y; Sakamoto N; Oo HZ; Naito Y; Uraoka N; Anami K; Sentani K; Oue N; Yasui W
    Pathol Int; 2012 Feb; 62(2):112-9. PubMed ID: 22243781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of CD133 in the cytoplasm is associated with cancer progression and poor prognosis in gastric cancer.
    Hashimoto K; Aoyagi K; Isobe T; Kouhuji K; Shirouzu K
    Gastric Cancer; 2014 Jan; 17(1):97-106. PubMed ID: 23558457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential expression of putative stem cell markers in gastric carcinogenesis.
    Wang T; Ong CW; Shi J; Srivastava S; Yan B; Cheng CL; Yong WP; Chan SL; Yeoh KG; Iacopetta B; Salto-Tellez M
    Br J Cancer; 2011 Aug; 105(5):658-65. PubMed ID: 21829201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of CD133, histone deacetylase 1 and thrombospondin-1 in gastric cancer.
    Eto S; Yoshikawa K; Shimada M; Higashijima J; Tokunaga T; Nakao T; Nishi M; Takasu C; Sato H; Kurita N
    Anticancer Res; 2015 Apr; 35(4):2071-6. PubMed ID: 25862862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of stem-like cells and clinical significance of candidate stem cell markers in gastric cancer.
    Zhang X; Hua R; Wang X; Huang M; Gan L; Wu Z; Zhang J; Wang H; Cheng Y; Li J; Guo W
    Oncotarget; 2016 Mar; 7(9):9815-31. PubMed ID: 26769843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of expression of CD133 and Ki-67 in gastric cancer.
    Saricanbaz I; Karahacioglu E; Ekinci O; Bora H; Kilic D; Akmansu M
    Asian Pac J Cancer Prev; 2014; 15(19):8215-9. PubMed ID: 25339008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis.
    Han Z; Chen Z; Zheng R; Cheng Z; Gong X; Wang D
    World J Surg Oncol; 2015 Feb; 13():56. PubMed ID: 25889325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value for lymph node metastasis of epithelial-mesenchymal transition and cancer stem cell marker expression in early gastric cancer.
    Nam KH; Yoon H; Lee K; Park DJ; Kim HH; Lee HS; Shin E
    Pathol Res Pract; 2017 Sep; 213(9):1221-1226. PubMed ID: 28595915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of in vitro driven expression signatures of CD133 stem cell marker and tumor stroma on clinical outcomes in gastric cancers.
    Kim TM; Ko YH; Ha SJ; Lee HH
    BMC Cancer; 2019 Feb; 19(1):119. PubMed ID: 30717708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-Expression of LGR5 and CD133 Cancer Stem Cell Predicts a Poor Prognosis in Patients With Gastric Cancer.
    Wattanawongdon W; Bathpho TS; Tongtawee T
    Turk J Gastroenterol; 2021 Mar; 32(3):261-268. PubMed ID: 34160355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoplasmic expression of CD133 stemness marker is associated with tumor aggressiveness in clear cell renal cell carcinoma.
    Saeednejad Zanjani L; Madjd Z; Abolhasani M; Andersson Y; Rasti A; Shariftabrizi A; Asgari M
    Exp Mol Pathol; 2017 Oct; 103(2):218-228. PubMed ID: 29050853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic significance of putative stem cell marker, CD44 and CD133, in human gastric carcinoma.
    Chen S; Hou JH; Feng XY; Zhang XS; Zhou ZW; Yun JP; Chen YB; Cai MY
    J Surg Oncol; 2013 Jun; 107(8):799-806. PubMed ID: 23609373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.